| Date | Title | Description |
| 09.08.2025 | Apreo Health Secures $130M to Revolutionize Emphysema Care | Apreo Health secured $130 million in Series B funding. This major investment propels its BREATHE Airway Scaffold, an innovative medical device for severe emphysema. The scaffold addresses lung hyperinflation, aiming to redefine treatment fo... |
| 08.08.2025 | Apreo Health: $130 Million Series B Raised For Developing Treatments For Severe Emphysema | Apreo Health, a clinical-stage medical device company focused on innovative treatments for severe emphysema, has announced the successful completion of an oversubscribed $130 million Series B financing round. This funding was jointly led by... |
| 07.08.2025 | Apreo Health Closes $130M in Series B Financing | Apreo Health, a Menlo Park, CA-based clinical-stage medical device company developing a novel treatment for severe emphysema, raised $130M in Series B funding.
The round was led by Bain Capital Life Sciences and Norwest, with participation ... |
| 02.06.2025 | Clairity Becomes the First FDA-Authorized AI Platform for Breast Cancer Prediction – Historic Milestone for Women’s Health | CLAIRITY BREAST provides clinicians with a first-in-class, novel platform for identifying future risk of breast cancer
A milestone in equitable healthcare, with potentially life-saving insights from a screening mammogram alone
FDA grants De... |
| 12.06.2020 | $29M investment to develop new treatment for type 2 diabetes | An orally administered treatment for type 2 diabetes (T2D), which mirrors the astonishing effect of gastric bypass surgery in improving sugar control in diabetes patients, has received a Series A investment of AU$29m. |
| 12.06.2020 | Glyscend Therapeutics Completes $20.5 M Series A | Glyscend Therapeutics, a privately held biopharmaceutical company developing novel treatments for type 2 diabetes (T2D) and related metabolic conditions, today announced the closing of a $20.5 million Series A financing round. Healthcare in... |
| 10.07.2019 | New Funds for Procyrion, Remedy, OncoNano, Vyopta & More TX Tech | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
[Updated 7/10/19, 11:41 am CT. See below.] Let’s catch up with the latest innovation news in Texas.
—Austin startup Vyopta, which makes a video conference system dashboard for... |
| 27.06.2019 | Austin-based Remedy Lands $10 Million in Funding from Austin-based Sante Ventures | Remedy, a healthcare service provider, announced Wednesday that it has raised $10 million. |
| 26.06.2019 | Santé Ventures Appoints Dennis McWilliams as VP | Dennis McWilliams, Venture Partner at Santé Ventures
Santé Ventures, a healthcare and life sciences investment firm, announced today the appointment of Dennis McWilliams as Venture Partner based in Austin, Texas.
In his new role at Santé Ve... |
| 25.06.2019 | Longtime Analyst Mark Mahaney: ‘The Bar Is Higher In the Public Markets:’ Term Sheet | ‘THE BAR IS HIGHER IN THE PUBLIC MARKETS’
We’re already halfway through the year, and a number of tech startups finally made their public market debut — Uber, Lyft, Zoom, Pinterest, PagerDuty, Beyond Meat, CrowdStrike, and most recently, Sl... |
| 02.06.2019 | Santé Ventures’ Kevin Lalande on how to drive returns in an era of overvaluation | Sante Ventures Managing Director Kevin Lalande
In an interview, Santé Ventures Managing Director Kevin Lalande shared how the company’s organizing investment philosophy and discipline is intended to “engineer the luck out of fund-level vent... |
| 30.05.2019 | Santé Ventures Raises $250M in Third Healthcare and Life Science Fund | Santé Ventures, an Austin, Texas-based healthcare and life sciences investment firm, closed its third fund, at $250m.
Fund III secured capital commitments from over 30 limited partners, including new investor Pennsylvania Public School Empl... |
| 29.05.2019 | Austin's Santé Ventures Closes $250M Life Science Fund | An Austin venture capital firm with a long history of investing in Texas health care and life sciences startups has secured a new $250 million fund that will help fuel 20-plus investments.
Santé Ventures, which was founded in 2006 and has m... |
| 29.05.2019 | Austin-based Santé Ventures Raises $250 Million Fund to Invest in Healthcare and Life Sciences Companies | Santé Ventures, a healthcare and life sciences investment firm specializing in early-stage companies, announced Wednesday it has closed a $250 million fund. |
| 24.11.2015 | Daily funding roundup - November 24, 2015 | Placester secured $27M; Shiftgig raised $22M; Fortscale announced $16M funding
Lenda, a first platform that allows homeowners to refinance their mortgage completely online, today announced the close of $2 million in seed funding led by Lake... |
| 29.10.2015 | Bizologie Provides Research Services to VCs and Startups | By LAURA LOREK
Reporter with Silicon Hills News |
| 06.10.2015 | Daily funding roundup - October 6, 2015 | Impossible Foods raised $108M; Code42 secured $85M; Canva bagged $21M
Mumbai-based Aasaanjobs Pvt. Ltd that owns and operates the online recruitment portal Aasaanjobs.com said on Wednesday that it has raised $1.5 million in funding from Inv... |
| 08.06.2015 | Pitching life sciences investors: Keep it simple, stupid. | Here’s the problem with nerds: You ask them the time, they tell you the history of clock making.
Or so says Richard Koffler, a life sciences investor with the California-based angel network Tech Coast Angels.
His core bit of advice? Keep it... |
| 04.12.2014 | More Venture Capital Needed for Life Science Startups | By LAURA LOREK
Reporter with Silicon Hills News |
| 05.02.2014 | Lumos Pharma Raises $14M in Series A Financing | Lumos Pharma, an Austin, Texas-based early stage biopharmaceutical development company, raised $14m in Series A financing.
The round was co-led by Sante Ventures and New Enterprise Associates (NEA). As part of the Series A financing, Kevin ... |
| 07.01.2014 | Incubator with six venture-backed spinouts seeks 2014 exit, unveils new sepsis spinout | The six venture-backed spinouts include:
Baronova, a startup trying for weight loss devices that are both non-surgical and non-pharma. The company closed a $27.3 million Series C round in February 2013, which was led by Boston Scientific (B... |
| 08.10.2013 | Molecular Templates Raises $8.5M Series C Financing | Molecular Templates, Inc., a Georgetown, TX-based biopharmaceutical company focused on the discovery and development of a new class of biologic therapeutics, raised an $8.5m Series C financing.
The round was led by Excel Venture Management,... |
| 11.06.2013 | TVA Medical Raises $9.5M in Series B Financing | TVA Medical, Inc., an Austin, Texas-based medical device company developing minimally invasive therapies for End-Stage Renal Disease (ESRD), raised $9.5m in Series B financing.
The round was led by S3 Ventures, with participation from TriSt... |
| 23.10.2012 | Spinal Restoration Closes $5M Financing | Spinal Restoration, Inc., an Austin, Texas-based developer of new therapies that address unmet needs in spine health management, has closed a$5m financing round.
The financing includes $3m in equity from existing investors Austin Ventures, ... |
| 25.04.2012 | Healthcare accelerators: Good for startups, not so good for VCs? | Joe Cunningham, a managing director with Austin, Texas-based Sante Ventures shared a rather staggering statistic that, if true, illustrates the kind of odds that accelerators are up against. Cunningham said he’s seen research that indicates... |
| 21.11.2011 | ChanRx Closes Series A Funding | ChanRx, a Cleveland, OH-based developer of a drug for treatment of atrial fibrillation (AFIB), has closed a Series A funding of undisclosed amount.
Backers include Sante Ventures and company founder, Dr. Arthur “Buzz” Brown.
The company pla... |
| 21.11.2011 | Drug developer ChanRx closes series A investment, hires CEO | ChanRx is developing vanoxerine, an anti-arrhythmia drug that has demonstrated an ability to restore normal heart rhythm in a human clinical study.
The drug has been shown to be safe in six phase 1 clinical trials. A phase 2a trial showed t... |
| 21.11.2011 | ChanRx Closes Series A Funding |
Firm developing a superior drug for treatment of atrial fibrillation (AFIB), has closed its Series A funding with investments from Sante Ventures and company founder, Dr. Arthur "Buzz" Brown.
>> Click here for more fundin... |
| 16.06.2011 | Dreaming of an IPO? Q&A with Explorys CEO Steve McHale | With all that cash going toward EMRs, there’s a strong need for a means of making sense of that data and uncovering any trends it holds that could improve patient care. Explorys believes it can fill that need, and some deep-pocketed investo... |
| 30.03.2011 | Cleveland Clinic: Both hospital and startup incubator | $28 million may be just the beginning.
That’s the return Cleveland Clinic received after the $78 million sale of Clinic spinoff Intelect Medical to Boston Scientific Corp. (NYSE:BSX).
It was the largest of three exits so far for companies a... |
| 29.03.2011 | Cleveland Clinic’s most promising startups | Promoted
Clinical Care Capacity Planning
Learn how to manage clinical care capacity more efficiently during uncertain times.
SAP
Promoted
This Patient Experience Checklist Is Your Key To Success in 2021
As healthcare systems strive to recov... |
| 01.11.2010 | Explorys adds hospitals to network that will harness medical data | Founded in 2009 by data management veterans McHale and Charlie Lougheed, Explorys provides data services and applications that enable healthcare providers, accountable care organizations, and biotech and pharmaceutical companies to improve ... |
| 02.08.2010 | Explorys raises $2.55M to take healthcare data analysis next step | Explorys will use its latest fundraise to continue developing platform technologies, such as drug-safety detection and third-party software development interfaces. The company of 15 people and growing also will use the money to develop its ... |
| 18.02.2010 | Rise Health of Chicago raises $1.5M for primary care support services | Promoted
Covid-19’s terrible toll on diabetes patients. What can be done?
The public health crisis has undermined the economy and made people with chronic conditions more vulnerable and stressed. Learn more with a new report from Omada Heal... |
| 17.12.2007 | Life sciences briefing: Monday, Dec. 17, 2007 | TODAY’S HEADLINES:
Specialty pharma Innocoll raises $30M for collagen technologies (release)
Immusol changes name to ItherX Pharma, names Jeffery McKelvy CEO (release)
Austin’s Santé Ventures raises $130M healthcare VC fund (release)
Belgiu... |
| - | Santé Ventures’ Kevin Lalande on how to drive returns in an era of overvaluation | Since its founding in 2006, Austin, Texas-based life science and healthcare investor Santé Ventures has backed more than 30 companies and established a steady track record of successful exits including Claret Medical (acquired by Boston Sci... |
| - | Cleveland Clinic’s most promising startups | $28 million may be just the beginning.
That’s the return Cleveland Clinic received after the $78 million sale of Clinic spinoff Intelect Medical to Boston Scientific (NYSE:BSX). It was the largest of three exits so far for companies affilia... |
| - | Rise Health of Chicago raises $1.5M for primary care support services | CHICAGO, Illinois — Rise Health Inc. has raised $1.5 million in equity for its primary care physician support services, according to a document filed with the Securities and Exchange Commission.
Seeking to help ease the burdens of the U.S. ... |
| - | Explorys adds hospitals to network that will harness medical data | Medical data management company Explorys Inc. has added three Northeast Ohio hospital systems to its emerging member network that’s aimed at harnessing information from burgeoning electronic records to improve patient outcomes.
MetroHealth ... |
| - | Dreaming of an IPO? Q&A with Explorys CEO Steve McHale | Credit Steve McHale for having a knack for putting himself in the right place at the right time.
Six years ago, McHale and partner Charlie Lougheed sold the previous company they founded, Everstream, for $15 million to Concurrent Computer. ... |
| - | Pitching life sciences investors: Keep it simple, stupid. | Here’s the problem with nerds: You ask them the time, they tell you the history of clock making.
Or so says Richard Koffler, a life sciences investor with the California-based angel network Tech Coast Angels.
His core bit of advice? Keep it... |
| - | Drug developer ChanRx closes series A investment, hires CEO | Drug developer ChanRx has closed a series A round of investment that it will use to fund clinical trials of a pharmaceutical to treat atrial fibrillation.
The Cleveland-area company, which was spun off from pharmaceutical testing firm ChanT... |
| - | Explorys raises $2.55M to take healthcare data analysis next step | Explorys Inc., the Cleveland, Ohio, startup that is putting healthcare data management, analytics and outcomes measurement on the Internet, has raised $2.55 million in Series B funding from Sante Ventures and Cleveland Clinic Innovations.
F... |
| - | Incubator with six venture-backed spinouts seeks 2014 exit, unveils new sepsis spinout | TheraNova is a San Francisco-based sandbox incubator and capital technology developer for medical devices. With one exception, all the ideas for technology are internally generated, CEO Dr. Daniel Burnett said. That’s led to all its medical... |
| - | Healthcare accelerators: Good for startups, not so good for VCs? | Panelists at a venture capital forum enthusiastically endorsed accelerators as providing plenty of value for entrepreneurs – mentorship, networking, business connections and the like.
But several VCs on the panel were less confident about w... |